Wei‐Chun Hsu
- Co-authors
- Hemanth KanakamedalaArt SedrakyanJialin MaoJuan Pablo ZarateStephen ChiaHope S. RugoStuart TurnerManuel Ruíz‐Borrego
- Topics
- Advanced Breast Cancer Therapies (3 papers)Cancer Treatment and Pharmacology (3 papers)CAR-T cell therapy research (2 papers)
- Journals
- BloodCancerThe Lancet Oncology
- Partner nations
- United StatesSwitzerlandGermany
In The Last Decade
Wei‐Chun Hsu
13 papers receiving 417 citations
Hit Papers
Peers
Comparison fields: 5 of 60
- Pulmonary and Respiratory Medicine 242
- Oncology 175
- Cancer Research 97
- Molecular Biology 95
- Genetics 60
Countries citing papers authored by Wei‐Chun Hsu
This map shows the geographic impact of Wei‐Chun Hsu's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Wei‐Chun Hsu with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Wei‐Chun Hsu more than expected).
Fields of papers citing papers by Wei‐Chun Hsu
This network shows the impact of papers produced by Wei‐Chun Hsu. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Wei‐Chun Hsu. The network helps show where Wei‐Chun Hsu may publish in the future.
Co-authorship network of co-authors of Wei‐Chun Hsu
This figure shows the co-authorship network connecting the top 25 collaborators of Wei‐Chun Hsu. A scholar is included among the top collaborators of Wei‐Chun Hsu based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Wei‐Chun Hsu. Wei‐Chun Hsu is excluded from the visualization to improve readability, since they are connected to all nodes in the network.
All Works
| # | Work | Indexed citations |
|---|---|---|
| 1 | 1 | |
| 2 | 0 | |
| 3 | 10 | |
| 4 | 3 | |
| 5 | 5 | |
| 6 | 1 | |
| 7 | Alpelisib plus fulvestrant in PIK3CA-mutated, hormone receptor-positive advanced breast cancer after a CDK4/6 inhibitor (BYLieve): one cohort of a phase 2, multicentre, open-label, non-comparative studybreakdown → | 223 |
| 8 | 23 | |
| 9 | 2 | |
| 10 | 14 | |
| 11 | 18 | |
| 12 | 36 | |
| 13 | 1 | |
| 14 | 27 | |
| 15 | 60 |
About Wei‐Chun Hsu
Wei‐Chun Hsu is a scholar working on Applied Microbiology and Biotechnology, Oncology and Molecular Medicine, having authored 15 papers that have together received 424 indexed citations. Recurring topics across this work include Advanced Breast Cancer Therapies (3 papers), Cancer Treatment and Pharmacology (3 papers) and CAR-T cell therapy research (2 papers). The work is most often cited by research in Pulmonary and Respiratory Medicine (242 citations), Cancer Research (97 citations) and Oncology (175 citations). Wei‐Chun Hsu has collaborated with scholars based in United States, Switzerland and Germany. Frequent co-authors include Hemanth Kanakamedala, Art Sedrakyan, Jialin Mao, Juan Pablo Zarate, Stephen Chia, Hope S. Rugo, Stuart Turner, Manuel Ruíz‐Borrego, Eva Ciruelos and Thomas Bachelot. Their work appears in journals such as Blood, Cancer and The Lancet Oncology.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.